Abstract | BACKGROUND: The role of nitric oxide (NO) production because of inducible nitric oxide synthase (iNOS) in the pathogenesis of renal ischemia/reperfusion (I/R) injury is unclear. In this study the roles of both iNOS and NO were characterized in a rat model of renal I/R injury. In addition, the effect of iNOS inhibition on renal function was evaluated. METHODS: Sprague-Dawley rats underwent 45 min of left renal ischemia and contralateral nephrectomy followed by various periods of reperfusion and renal function analysis [plasma creatinine, fractional excretion of sodium (FENa), creatinine clearance (CrCl), and measurement of plasma and urine NO levels]. In addition, the effect of treatment with 1400W, a highly selective iNOS inhibitor, was evaluated. RESULTS: Renal dysfunction peaked at 48 h after reperfusion and immunohistochemistry studies revealed iNOS expression in the vasculature (3 h) and renal tubules (48 h) after reperfusion. Renal function improved significantly in treated animals compared to controls [ creatinine of 1.1 v. 1.9 mg/dl (P < 0.05) and CrCl of 0.54 v. 0.31 ml/min (P < 0.05), respectively]. In addition, FENa was decreased by 50%, plasma NO levels were significantly lower (32.7 v. 45.7 micromol/L, P < 0.01), and deposition of nitrotyosine in the tubules of treated rats was less than in control animals. CONCLUSIONS: These data support the hypothesis that iNOS and NO are involved in the pathogenesis of renal I/R injury and suggests that use of iNOS inhibitors may be a valuable therapeutic strategy clinical situations where renal I/R may be prevalent.
|
Authors | Lisa A Mark, Ann V Robinson, James A Schulak |
Journal | The Journal of surgical research
(J Surg Res)
Vol. 129
Issue 2
Pg. 236-41
(Dec 2005)
ISSN: 0022-4804 [Print] United States |
PMID | 16140334
(Publication Type: Journal Article)
|
Chemical References |
- Amidines
- Benzylamines
- Endothelins
- Enzyme Inhibitors
- N-(3-(aminomethyl)benzyl)acetamidine
- Nitric Oxide
- 3-nitrotyrosine
- Tyrosine
- Creatinine
- Nitric Oxide Synthase Type II
- Nos2 protein, rat
|
Topics |
- Amidines
(pharmacology)
- Animals
- Benzylamines
(pharmacology)
- Creatinine
(blood)
- Disease Models, Animal
- Endothelins
(blood)
- Enzyme Inhibitors
(pharmacology)
- Kidney Tubules
(blood supply, enzymology)
- Male
- Nitric Oxide
(blood)
- Nitric Oxide Synthase Type II
(antagonists & inhibitors, metabolism)
- Rats
- Rats, Sprague-Dawley
- Reperfusion Injury
(drug therapy, metabolism)
- Tyrosine
(analogs & derivatives, metabolism)
|